Detailed information for compound 1553512

Basic information

Technical information
  • TDR Targets ID: 1553512
  • Name: 2-(benzyl-(4,5-dihydro-1,3-thiazol-2-yl)amino )-1-(4-methoxyphenyl)ethanone hydrobromide
  • MW: 421.351 | Formula: C19H21BrN2O2S
  • H donors: 0 H acceptors: 1 LogP: 4.2 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1)C(=O)CN(C1=NCCS1)Cc1ccccc1.Br
  • InChi: 1S/C19H20N2O2S.BrH/c1-23-17-9-7-16(8-10-17)18(22)14-21(19-20-11-12-24-19)13-15-5-3-2-4-6-15;/h2-10H,11-14H2,1H3;1H
  • InChiKey: GKBGXMOJOOQIIX-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 2-(benzyl-(4,5-dihydrothiazol-2-yl)amino)-1-(4-methoxyphenyl)ethanone hydrobromide
  • 2-(4,5-dihydro-1,3-thiazol-2-yl-(phenylmethyl)amino)-1-(4-methoxyphenyl)ethanone hydrobromide
  • MLS000392331
  • SMR000261201

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens glucagon-like peptide 1 receptor Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Loa Loa (eye worm) pigment dispersing factor receptor c glucagon-like peptide 1 receptor 463 aa 388 aa 25.8 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Plasmodium vivax DNA gyrase subunit B, putative 0.0545 1 1
Brugia malayi DNA topoisomerase II, alpha isozyme 0.0127 0.1385 1
Trypanosoma cruzi mitochondrial DNA topoisomerase II, putative 0.0315 0.5256 1
Mycobacterium ulcerans DNA gyrase subunit B 0.0545 1 0.5
Wolbachia endosymbiont of Brugia malayi DNA gyrase, topoisomerase II, B subunit, GyrB 0.0545 1 0.5
Onchocerca volvulus DNA topoisomerase 2 homolog 0.0127 0.1385 0.5
Onchocerca volvulus DNA topoisomerase 2 homolog 0.0127 0.1385 0.5
Onchocerca volvulus Putative DNA topoisomerase 2, mitochondrial 0.0127 0.1385 0.5
Leishmania major mitochondrial DNA topoisomerase II 0.0315 0.5256 1
Loa Loa (eye worm) TOPoisomerase family member 0.0127 0.1385 1
Trypanosoma brucei DNA topoisomerase ii 0.0315 0.5256 1
Loa Loa (eye worm) hypothetical protein 0.0088 0.0582 0.4199
Toxoplasma gondii ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein 0.0315 0.5256 1
Echinococcus multilocularis DNA topoisomerase 2 alpha 0.0127 0.1385 0.5
Echinococcus granulosus DNA topoisomerase 2 alpha 0.0127 0.1385 0.5
Brugia malayi DNA gyrase/topoisomerase IV, A subunit family protein 0.0127 0.1385 1
Mycobacterium tuberculosis DNA gyrase (subunit B) GyrB (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (type II DNA topoisomerase) 0.0545 1 0.5
Trichomonas vaginalis DNA topoisomerase II, putative 0.0127 0.1385 0.5
Trypanosoma cruzi mitochondrial DNA topoisomerase II, putative 0.0315 0.5256 1
Giardia lamblia DNA topoisomerase II 0.011 0.1033 0.5
Entamoeba histolytica DNA topoisomerase II, putative 0.0127 0.1385 0.5
Treponema pallidum DNA gyrase, subunit B (gyrB) 0.0545 1 0.5
Loa Loa (eye worm) hypothetical protein 0.0088 0.0582 0.4199
Schistosoma mansoni DNA topoisomerase II 0.0127 0.1385 0.5
Brugia malayi Probable DNA topoisomerase II 0.0127 0.1385 1
Mycobacterium leprae Probable DNA gyrase (subunit B) GyrB (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (Type II DNA topoisomerase) 0.0188 0.2629 0.5
Plasmodium falciparum DNA gyrase subunit B 0.0545 1 1

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 5.6234 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 89.1251 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.